(Q53273186)

12 May 2018

title

Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. (English)

1 reference

12 May 2018

1 reference

6

1 reference

12 May 2018

Michael R. Horsman

7

1 reference

12 May 2018

Ole L. Munk

2

object named as

Ole Lajord Munk

1 reference

12 May 2018

author name string

Morten Busk

1

1 reference

12 May 2018

Steen Jakobsen

3

1 reference

12 May 2018

Tobias Wang

4

1 reference

12 May 2018

Marianne Skals

5

1 reference

12 May 2018

Jens Overgaard

8

1 reference

12 May 2018

publication date

1 October 2010

1 reference

12 May 2018

published in

Acta Oncologica

1 reference

12 May 2018

volume

49

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

page(s)

922-933

1 reference

12 May 2018

Tumor hypoxia and malignant progression.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Influence of oxygen concentration and pH on expression of hypoxia induced genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Resolution in PET hypoxia imaging: voxel size matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

The limitation of PET imaging for biological adaptive-IMRT assessed in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

18FFluoroazomycinarabinofuranoside (18FAZA) and 18FFluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.503970

10.3109/0284186X.2010.503970

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018